Le Lézard
Classified in: Health
Subject: AVO

Should Secondary Findings in Genetics Be Used for General Population Screening? A Policy Statement of the American College of Medical Genetics and Genomics (ACMG)


BETHESDA, Md., April 25, 2019 /PRNewswire/ -- The American College of Medical Genetics and Genomics (ACMG) has previously published recommendations on the reporting of secondary findings in clinical exome and genome sequencing. Secondary findings are health-related interpretations of a patient's genetic code that are unrelated to the primary reason for ordering the original testing. In order to promote standardized reporting of medically actionable information from clinical genomic sequencing, the ACMG in 2013, and then again in 2016, published a minimum list of genes to be reported as secondary findings during exome or genome sequencing (ACMG 56tm, ACMG SF v2.0tm). This list of recommended secondary findings to be reported reflects ACMG's commitment to giving the genetics community a voice about which genes to include to further the goal of providing people information that can have a huge impact on their health outcomes.  

Founded in 1991, the American College of Medical Genetics and Genomics (ACMG) is the only nationally recognized medical society dedicated to improving health through the clinical practice of medical genetics and genomics. (PRNewsfoto/American College of Medical G...)

Now, the ACMG has published a follow-up statement regarding whether secondary findings in genetics should be used for general population screening: "The Use of ACMG Secondary Findings Recommendations for General Population Screening ? a Policy Statement of the American College of Medical Genetics and Genomics."

The ACMG statement stresses that the recommended list of genes for inclusion in reporting to patients was not validated or intended for general population screening. ACMG's new statement clearly states that the use of ACMG SFv2.0 for purposes other than reporting incidental findings after clinical sequencing is not endorsed by ACMG.

"The reporting of secondary findings raises many difficult questions and ACMG has been a leader in addressing these issues. New challenges arose when ACMG SF v2.0 was extrapolated for use in the general population. The ACMG Board of Directors felt it was important to address concerns raised by many members in such situations," said ACMG President Tony Gregg, MD, MBA, FACOG, FACMG, co-author of the new ACMG statement.

The document also states:

"The use of ACMG secondary findings recommendations for general population screening ? a policy statement of the American College of Medical Genetics and Genomics" is available at: https://www.nature.com/articles/s41436-019-0502-5

About the American College of Medical Genetics and Genomics (ACMG) and ACMG Foundation

Founded in 1991, the American College of Medical Genetics and Genomics (ACMG) is the only nationally recognized medical society dedicated to improving health through the clinical practice of medical genetics and genomics. The ACMG provides education, resources and a voice for more than 2,300 biochemical, clinical, cytogenetic, medical and molecular geneticists, genetic counselors and other healthcare professionals, nearly 80% of whom are board certified in the medical genetics specialties. The College's mission is to develop and sustain medical genetics-related initiatives in clinical and laboratory practice, education and advocacy.

Four overarching strategies guide ACMG's work: 1) to reinforce and expand ACMG's position as the leader and prominent authority in the field of medical genetics and genomics while educating the medical community on the significant role that genetics and genomics will play in understanding, preventing, treating and curing disease; 2) to secure and expand the professional workforce for medical genetics and genomics; 3) to advocate for the specialty; and 4) to provide best-in-class education to members and nonmembers. Genetics in Medicine, published monthly, is the official ACMG peer-reviewed journal. ACMG's website (http://www.acmg.net/) offers resources including policy statements, practice guidelines, educational programs and a 'Find a Genetic Service' tool. The educational and public health programs of the ACMG are dependent upon charitable gifts from corporations, foundations and individuals through the ACMG Foundation for Genetic and Genomic Medicine.

Kathy Moran, MBA
[email protected]

 

SOURCE American College of Medical Genetics and Genomics


These press releases may also interest you

at 00:25
Shanghai Junshi Biosciences Co., Ltd ("Junshi Biosciences," HKEX: 1877; SSE: 688180), a leading innovation-driven biopharmaceutical company dedicated to the discovery, development, and commercialization of novel therapies, announced its financial...

28 mar 2024
The report titled "Central Lab Market by Service Type (Anatomic Pathology/Histology, Biomarker Services, Genetic Services), Phase (Phase 1, Phase 2, Phase 3), Therapeutic Area, End-use - Global Forecast 2024-2030" is now available on...

28 mar 2024
The report titled "Personalized Nutrition Market by Measurement Type (Active Measurement, Standard Measurement), Application (Indication-based, Standard Supplements), Distribution Channel, End-Use - Global Forecast 2024-2030" is now available on...

28 mar 2024
The report titled "Carbon Dioxide Incubator Market by Product (Air Jacketed CO2 Incubators, Direct Heat CO2 Incubators, Water Jacketed CO2 Incubators), Capacity (100-200 Litre, Above 200 Litre, Below 100 Litre), Application, End User - Global...

28 mar 2024
The "Global Clinical In Vitro Diagnostic Medical Laboratory Services Market: Strategy & Trends with Volume & Price Forecasts by Chemistry, Hematology, Microbiology, Pathology, Covid-19, and Molecular Dx by Country. Updated with Impact of COVID-19"...

28 mar 2024
The "Molecular Diagnostics at the Point of Care. By Application, Technology, Place, Product and by Country. With Executive Guides and Customization 2023 - 2027 " report has been added to  ResearchAndMarkets.com's offering. Infectious disease Dx is...



News published on and distributed by: